Top Back to top

Elderly AML: A randomised Phase III study comparing conventional chemotherapy to low dose total body irradiation-based conditioning and hematopoietic stem cell transplantation from related and unrelated donors as consolidation therapy for older patients with AML in 1st complete remission

Study number:
2007-003514-34
Type of transplant:
 
Short title:
HSCT vs CT in Elderly AML
Study status:
Recruiting Patients
Deadline for data collection:
 
Study design:
Randomised, controlled, open, multicentre, phase III trial
Primary objective:
Efficacy of allogeneic related or unrelated heamtopoietic cell transplantation (HCT) after reduced intensityconditioning as a consolidation treatment for elderly patietns with AML in complete remission
Key inclusion criteria:
>=60, <=75 years old
Country:
Australia
Austria
Belgium
France
Germany
Netherlands
Switzerland
Principal investigator:
Dietger Niederwieser
Principal investigator email:
 
EBMT Study coordinator:
Ruzena Uddin